Lisa Hayes, right, assistant director of Marketing, shows off the new branding campaign on the Vanderbilt Web site to Denise Leveque of Cardiology.
Photo by Dana Johnson
VICC cancer meet highlights advances
Cancer clinicians from throughout the Southeast gathered over the weekend to learn about the practice-changing implications of research presented at the recent American Society of Clinical Oncology (ASCO) annual meeting.
The event was the third annual Oncology Review Symposium, hosted by Vanderbilt-Ingram Cancer Center.
ASCO's annual meeting last month in Atlanta drew nearly 30,000 attendees and included more than 4,400 abstracts presented in 27 different session tracks over four days.
The Oncology Review Symposium on July 8 at the Loews Vanderbilt Plaza attracted more than 125 attendees from 10 states and presentations from 11 faculty representing Vanderbilt-Ingram, Memorial Sloan Kettering Cancer Center and Emory University-Winship Cancer Institute.
Vanderbilt-Ingram began the symposium in 2004 to address educational needs of its own physicians as well as those throughout the region.
“ASCO's annual meeting is the largest oncology meeting in the world,” said Bruce Roth, M.D., professor of Medicine and symposium director.
“Many cancer clinicians are unable to attend, and for those who do attend, there is absolutely no way to cover everything because of the sheer volume of information being presented.”
Alan Sandler, M.D., associate professor of Medicine and Roth's co-symposium director, agreed.
“We want to distill the overwhelming amount of data into meaningful, concise information that can be put into practice and truly make a difference for cancer patients,” he said.